Show simple item record

dc.contributor.authorTABAK, Levent
dc.contributor.authorOzkan, DİDEM
dc.contributor.authorBayram, MEHMET
dc.contributor.authorErdogan, EZGİ BAŞAK
dc.contributor.authorYAKAR, Fatih
dc.contributor.authorSEZER, Murat
dc.contributor.authorOZCELIK, Hatice K.
dc.contributor.authorYAKAR, Aysun
dc.date.accessioned2019-10-05T23:08:24Z
dc.date.available2019-10-05T23:08:24Z
dc.date.issued2015-04-01
dc.identifier10.1097/scs.0000000000003484
dc.identifier.urihttps://hdl.handle.net/20.500.12645/9525
dc.description.abstractBackground and aim Sarcoidosis is a multisystem disease of unknown origin. Determining the involvement and the response to the treatment is important. The aim of this study was to identify the effects of methylprednisolone and indomethacine on metabolic activity and pulmonary function test parameters in patients with sarcoidosis.
dc.language.isoen
dc.subjectYAKAR A., YAKAR F., SEZER M., Bayram M., Erdogan E. B. , Ozkan D., OZCELIK H. K. , TABAK L., -Use of PET-CT for the assessment of treatment results in patients with sarcoidosis-, WIENER KLINISCHE WOCHENSCHRIFT, cilt.127, ss.274-282, 2015
dc.titleUse of PET-CT for the assessment of treatment results in patients with sarcoidosis
dc.typeArticle
local.avesis.response9398
local.article.journalnameThe Journal of craniofacial surgery
dc.identifier.wosWOS:000354549100007
dc.identifier.scopus84939950388
dc.identifier.doi10.1007/s00508-014-0647-9
dc.identifier.pubmed25447964
local.publication.isinternational1


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record